EN
HI
Glaxosmithkline Pharmaceuticals Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
1.22 L
Market Cap
41321.52 CR
LTQ@LTP
1@2439.20
ATP
2449.06
Var Margin
16.13 %
Circuit Range
1977.6-2966.4
Delivery %
58.36 %
Value
29.84 CR
ASM/GSM
No
Market Lot
1
Summary
Glaxosmithkline Pharmaceuticals share price stands at ₹2439.2 at 27 Apr, 2026 | 15:58. The stock Glaxosmithkline Pharmaceuticals intraday movement has stayed between ₹2427.00 and ₹2495.00, while on a 52-week basis it has fluctuated from ₹2217.60 to ₹3515.70.
In terms of trading activity, Glaxosmithkline Pharmaceuticals has recorded a volume of 121838 shares. The Glaxosmithkline Pharmaceuticals has a market cap of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹244906, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 243920.
The Glaxosmithkline Pharmaceuticals operates within a circuit range of ₹1977.6-2966.4 – ₹1977.6-2966.4, with a Value of ₹29.84 CR. The Delivery Percentage for the day is 58.36%. Additionally, Glaxosmithkline Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Glaxosmithkline Pharmaceuticals Fundamentals
View MoreP/E Ratio
41.03
P/B Ratio
20.91
Div. Yield
2.18
Sector P/E
63.82
Sector P/B
3.5
Sec. Div. Yield
0.57
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2480.47
Resistance
First Resistance
2501.14
Second Resistance
2530.27
Third Resistance
2550.94
Support
First Support
2451.34
Second Support
2430.67
Third Support
2401.54
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 31St March 2026 And Dividend If Any
GlaxoSmithKline Pharmaceuticals board will convene on May 13, 2026. The meeting will focus on approving the audited financial results for Q4 FY26 and the full financial year, and considering a dividend recommendation.
Apr 22 2026 12:04:00
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals' Board authorized key personnel to determine the materiality of any event or transaction for stock exchange disclosures. This ensures compliance with SEBI Regulation 30(5). The authorized individuals include the Managing Director, CFO, Company Secretary, and Head of Legal.
Apr 21 2026 11:04:00
Read More
About Glaxosmithkline Pharmaceuticals
NSE : 1153
BSE : 500660
ISIN : INE159A01016
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Glenmark Pharmaceuticals Ltd.
2325.10
25.60 (1.11%)
Alkem Laboratories Ltd.
5344.00
109.00 (2.08%)
Laurus Labs Ltd.
1123.55
10.10 (0.91%)
Biocon Ltd.
362.00
12.15 (3.47%)
Abbott India Ltd.
25425.00
245.00 (0.97%)
Anthem Biosciences Ltd.
769.75
30.20 (4.08%)
Ipca Laboratories Ltd.
1541.30
-14.60 (0.94%)
Aster DM Healthcare Ltd.
719.80
14.55 (2.06%)
Narayana Hrudayalaya Ltd.
1790.40
22.10 (1.25%)
Ajanta Pharma Ltd.
2807.20
41.90 (1.52%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2439.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 41.03. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 20.91. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 41321.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3515.70 & 2217.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
